Reported Earnings • May 16
Full year 2026 earnings released: EPS: ₹45.95 (vs ₹37.29 in FY 2025) Full year 2026 results: EPS: ₹45.95 (up from ₹37.29 in FY 2025). Revenue: ₹98.3b (up 161% from FY 2025). Net income: ₹2.93b (up 27% from FY 2025). Profit margin: 3.0% (down from 6.1% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Feb 11
Third quarter 2026 earnings released: EPS: ₹10.79 (vs ₹9.18 in 3Q 2025) Third quarter 2026 results: EPS: ₹10.79 (up from ₹9.18 in 3Q 2025). Revenue: ₹25.5b (up 162% from 3Q 2025). Net income: ₹675.7m (up 19% from 3Q 2025). Profit margin: 2.6% (down from 5.8% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Nov 25
India Glycols Limited announced that it has received INR 4.669944975 billion in funding from a group of investors On November 24, 2025, India Glycols Limited closed the transaction. Reported Earnings • Nov 16
Second quarter 2026 earnings released: EPS: ₹10.51 (vs ₹8.03 in 2Q 2025) Second quarter 2026 results: EPS: ₹10.51 (up from ₹8.03 in 2Q 2025). Revenue: ₹24.1b (up 151% from 2Q 2025). Net income: ₹650.6m (up 31% from 2Q 2025). Profit margin: 2.7% (down from 5.2% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 39% per year and the company’s share price has also increased by 39% per year. Announcement • Oct 17
India Glycols Limited announced that it expects to receive INR 4.669944975 billion in funding from Kashipur Holdings Limited, 360 ONE Portfolio Managers Limited, QRG Investments and Holdings Limited, Rose Farms (Delhi) Private Limited India Glycols Limited announces that it has announced a private placement with Kashipur Holdings Limited, 360 One Pipe Fund and others to issue 5,103,765 Equity Shares at a price of INR 915 per share for gross proceeds of INR 4,669,944,975 on October 16, 2025. Upcoming Dividend • Sep 16
Upcoming dividend of ₹10.00 per share Eligible shareholders must have bought the stock before 23 September 2025. Payment date: 30 October 2025. Payout ratio is a comfortable 13% but the company is not cash flow positive. Trailing yield: 1.2%. Within top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%). Announcement • Sep 05
India Glycols Limited announces Annual dividend, payable on October 30, 2025 India Glycols Limited announced Annual dividend of INR 10.0000 per share payable on October 30, 2025, ex-date on September 23, 2025 and record date on September 23, 2025. Announcement • Sep 02
India Glycols Limited, Annual General Meeting, Sep 30, 2025 India Glycols Limited, Annual General Meeting, Sep 30, 2025, at 11:00 Indian Standard Time. Reported Earnings • Aug 08
First quarter 2026 earnings released: EPS: ₹23.66 (vs ₹19.50 in 1Q 2025) First quarter 2026 results: EPS: ₹23.66 (up from ₹19.50 in 1Q 2025). Revenue: ₹25.0b (up 159% from 1Q 2025). Net income: ₹732.5m (up 21% from 1Q 2025). Profit margin: 2.9% (down from 6.2% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Aug 01
India Glycols Limited to Report Q1, 2026 Results on Aug 07, 2025 India Glycols Limited announced that they will report Q1, 2026 results on Aug 07, 2025 New Risk • May 17
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.6% Last year net profit margin: 5.3% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.5x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.6% net profit margin). Reported Earnings • May 17
Full year 2025 earnings released: EPS: ₹74.58 (vs ₹55.87 in FY 2024) Full year 2025 results: EPS: ₹74.58 (up from ₹55.87 in FY 2024). Revenue: ₹90.5b (up 175% from FY 2024). Net income: ₹2.31b (up 34% from FY 2024). Profit margin: 2.6% (down from 5.3% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 21% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • May 13
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹1,643, the stock trades at a trailing P/E ratio of 24.3x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 70% over the past three years. Announcement • May 10
India Glycols Limited to Report Q4, 2025 Results on May 16, 2025 India Glycols Limited announced that they will report Q4, 2025 results on May 16, 2025 Valuation Update With 7 Day Price Move • Apr 17
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹1,424, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 44% over the past three years. Reported Earnings • Feb 05
Third quarter 2025 earnings released: EPS: ₹18.35 (vs ₹13.45 in 3Q 2024) Third quarter 2025 results: EPS: ₹18.35 (up from ₹13.45 in 3Q 2024). Revenue: ₹24.3b (up 169% from 3Q 2024). Net income: ₹568.1m (up 37% from 3Q 2024). Profit margin: 2.3% (down from 4.6% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Feb 04
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹1,414, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 65% over the past three years. Announcement • Jan 28
India Glycols Limited to Report Q3, 2025 Results on Feb 04, 2025 India Glycols Limited announced that they will report Q3, 2025 results on Feb 04, 2025 Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹1,414, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 61% over the past three years. Announcement • Dec 31
India Glycols Limited Announces Resignation of Rakesh Kumar, Chief Human Resource Officer India Glycols Limited informed that Mr. Rakesh Kumar, Chief Human Resource Officer (CHRO), a senior management person, has tendered his resignation. The Company has accepted his resignation with effect from the closure of business hours on 31 December 2024. Valuation Update With 7 Day Price Move • Dec 02
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹1,359, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 61% over the past three years. Reported Earnings • Nov 08
Second quarter 2025 earnings released: EPS: ₹16.06 (vs ₹12.27 in 2Q 2024) Second quarter 2025 results: EPS: ₹16.06 (up from ₹12.27 in 2Q 2024). Revenue: ₹21.5b (up 177% from 2Q 2024). Net income: ₹497.1m (up 31% from 2Q 2024). Profit margin: 2.3% (down from 4.9% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Announcement • Oct 31
India Glycols Limited to Report Q2, 2025 Results on Nov 07, 2024 India Glycols Limited announced that they will report Q2, 2025 results on Nov 07, 2024 Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹1,471, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 65% over the past three years. Announcement • Sep 21
India Glycols Limited Announces Director Changes, Effective September 30, 2024 India Glycols Limited approved the cessation of Mr. Pradip Kumar Khaitan, Mr. Jagmohan N. Kejriwal, Mr. Ravi Jhunjhunwala, and Mr. Jitender Balakrishnan as Independent Directors of the company upon the completion of their second term, with effect from the close of business hours on 30th September 2024. Announcement • Aug 28
India Glycols Limited Approves Dividend for the Financial Year Ended 31 March 2024 India Glycols Limited announced that at its AGM held on 28 August 2024, the shareholders approved dividend of INR 8 per equity share for the financial year ended 31 March 2024. Upcoming Dividend • Aug 14
Upcoming dividend of ₹8.00 per share Eligible shareholders must have bought the stock before 21 August 2024. Payment date: 27 September 2024. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.1%). In line with average of industry peers (0.7%). Announcement • Jul 30
India Glycols Limited, Annual General Meeting, Aug 28, 2024 India Glycols Limited, Annual General Meeting, Aug 28, 2024, at 11:00 Indian Standard Time. Reported Earnings • Jul 30
First quarter 2025 earnings released: EPS: ₹19.50 (vs ₹16.52 in 1Q 2024) First quarter 2025 results: EPS: ₹19.50 (up from ₹16.52 in 1Q 2024). Revenue: ₹22.9b (up 232% from 1Q 2024). Net income: ₹603.8m (up 18% from 1Q 2024). Profit margin: 2.6% (down from 7.4% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jul 25
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹1,175, the stock trades at a trailing P/E ratio of 21.1x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 75% over the past three years. Announcement • Jul 22
India Glycols Limited to Report Q1, 2025 Results on Jul 29, 2024 India Glycols Limited announced that they will report Q1, 2025 results at 3:30 PM, Indian Standard Time on Jul 29, 2024 Valuation Update With 7 Day Price Move • Jun 07
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹870, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 64% over the past three years. Announcement • May 30
India Glycols Limited Recommends Dividend for the Financial Year Ended 31St March, 2024 Board of Directors of India Glycols Limited in its meeting held on 28th May, 2024 has, inter-alia, considered and approved Recommended a dividend of INR 8/- per equity share (@ 80%) of face value of INR 10/- each for the financial year ended 31st March, 2024 which, if confirmed/declared by the members at the upcoming Annual General Meeting ("AGM"), will be paid/dispatched within 30 days from the date of AGM. Reported Earnings • May 29
Full year 2024 earnings released: EPS: ₹55.87 (vs ₹40.40 in FY 2023) Full year 2024 results: EPS: ₹55.87 (up from ₹40.40 in FY 2023). Revenue: ₹79.5b (up 200% from FY 2023). Net income: ₹1.73b (up 38% from FY 2023). Profit margin: 2.2% (down from 4.7% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Announcement • May 23
India Glycols Limited to Report Q4, 2024 Results on May 28, 2024 India Glycols Limited announced that they will report Q4, 2024 results on May 28, 2024 Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹871, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 103% over the past three years. Reported Earnings • Feb 03
Third quarter 2024 earnings released: EPS: ₹13.45 (vs ₹16.16 in 3Q 2023) Third quarter 2024 results: EPS: ₹13.45 (down from ₹16.16 in 3Q 2023). Revenue: ₹21.2b (up 284% from 3Q 2023). Net income: ₹416.3m (down 17% from 3Q 2023). Profit margin: 2.0% (down from 9.0% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings. Announcement • Jan 26
India Glycols Limited to Report Q3, 2024 Results on Feb 02, 2024 India Glycols Limited announced that they will report Q3, 2024 results on Feb 02, 2024 Reported Earnings • Nov 04
Second quarter 2024 earnings released: EPS: ₹12.27 (vs ₹7.62 in 2Q 2023) Second quarter 2024 results: EPS: ₹12.27 (up from ₹7.62 in 2Q 2023). Revenue: ₹18.8b (up 181% from 2Q 2023). Net income: ₹380.1m (up 61% from 2Q 2023). Profit margin: 2.0% (down from 3.5% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Nov 04
India Glycols Limited Appoints Shri Vishal Shishodia as Head - Imfl (Sales & Marketing) India Glycols Limited announced appointment of Shri Vishal Shishodia as Head - IMFL (Sales & Marketing) in the category of Senior Management Personnel, on recommendation of the Nomination & Remuneration Committee, of the Company with effect from 3 November, 2023. Announcement • Oct 28
India Glycols Limited to Report Q2, 2023 Results on Nov 03, 2023 India Glycols Limited announced that they will report Q2, 2023 results on Nov 03, 2023 Announcement • Sep 13
India Glycols Limited Announces Cessation of Tejinder Paul Sharma as Head IMFL (Sales & Marketing) India Glycols Limited announced that Mr. Tejinder Paul Sharma, Head IMFL (Sales & Marketing) ceases to be a Senior Management Person of the Company on attaining superannuation with effect from close of business hours of 12th September, 2023. Upcoming Dividend • Aug 29
Upcoming dividend of ₹7.50 per share at 1.0% yield Eligible shareholders must have bought the stock before 05 September 2023. Payment date: 12 October 2023. Payout ratio is a comfortable 19% but the company is not cash flow positive. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.8%). Valuation Update With 7 Day Price Move • Aug 14
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹733, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 163% over the past three years. Reported Earnings • Aug 08
First quarter 2024 earnings released: EPS: ₹16.52 (vs ₹8.91 in 1Q 2023) First quarter 2024 results: EPS: ₹16.52 (up from ₹8.91 in 1Q 2023). Revenue: ₹19.0b (up 135% from 1Q 2023). Net income: ₹511.4m (up 76% from 1Q 2023). Profit margin: 2.7% (down from 3.6% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Aug 01
India Glycols Limited to Report Q1, 2024 Results on Aug 07, 2023 India Glycols Limited announced that they will report Q1, 2024 results on Aug 07, 2023 Board Change • Jul 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 7 highly experienced directors. Additional Whole Time Director Pragya Barwale was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Announcement • May 25
India Glycols Limited Recommends Dividend for the Financial Year Ended 31 March, 2023 India Glycols Limited Recommended a dividend of INR 7.50/- per equity share (@75%) of face value of INR 10/- each for the financial year ended 31st March, 2023 which, if confirmed/declared by the members at the ensuing Annual General Meeting ("AGM"), will be paid/dispatched within 30 days from the date of AGM. Reported Earnings • May 25
Full year 2023 earnings released: EPS: ₹45.55 (vs ₹106 in FY 2022) Full year 2023 results: EPS: ₹45.55 (down from ₹106 in FY 2022). Revenue: ₹66.7b (up 132% from FY 2022). Net income: ₹1.25b (down 62% from FY 2022). Profit margin: 1.9% (down from 12% in FY 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 19
India Glycols Limited to Report Q4, 2023 Results on May 24, 2023 India Glycols Limited announced that they will report Q4, 2023 results on May 24, 2023 Reported Earnings • Feb 10
Third quarter 2023 earnings released: EPS: ₹16.16 (vs ₹7.75 in 3Q 2022) Third quarter 2023 results: EPS: ₹16.16 (up from ₹7.75 in 3Q 2022). Revenue: ₹5.54b (down 30% from 3Q 2022). Net income: ₹500.3m (up 108% from 3Q 2022). Profit margin: 9.0% (up from 3.0% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 27% per year. Announcement • Feb 02
India Glycols Limited to Report Q3, 2023 Results on Feb 08, 2023 India Glycols Limited announced that they will report Q3, 2023 results on Feb 08, 2023 Reported Earnings • Nov 16
Second quarter 2023 earnings released: EPS: ₹7.62 (vs ₹12.04 in 2Q 2022) Second quarter 2023 results: EPS: ₹7.62 (down from ₹12.04 in 2Q 2022). Revenue: ₹6.70b (down 14% from 2Q 2022). Net income: ₹235.8m (down 37% from 2Q 2022). Profit margin: 3.5% (down from 4.8% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Nov 12
Second quarter 2023 earnings released: EPS: ₹7.62 (vs ₹12.04 in 2Q 2022) Second quarter 2023 results: EPS: ₹7.62 (down from ₹12.04 in 2Q 2022). Revenue: ₹16.4b (up 110% from 2Q 2022). Net income: ₹235.8m (down 37% from 2Q 2022). Profit margin: 1.4% (down from 4.8% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Aug 22
Upcoming dividend of ₹7.50 per share Eligible shareholders must have bought the stock before 29 August 2022. Payment date: 07 October 2022. Payout ratio is a comfortable 15% but the company is not cash flow positive. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (0.7%). Reported Earnings • Aug 11
First quarter 2023 earnings released First quarter 2023 results: Revenue: ₹8.14b (up 25% from 1Q 2022). Net income: ₹290.2m (down 86% from 1Q 2022). Profit margin: 3.6% (down from 31% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 53% per year whereas the company’s share price has increased by 56% per year. Reported Earnings • May 30
Full year 2022 earnings released: EPS: ₹106 (vs ₹35.27 in FY 2021) Full year 2022 results: EPS: ₹106 (up from ₹35.27 in FY 2021). Revenue: ₹28.7b (up 24% from FY 2021). Net income: ₹3.30b (up 202% from FY 2021). Profit margin: 12% (up from 4.7% in FY 2021). Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 49% per year. Valuation Update With 7 Day Price Move • May 18
Investor sentiment improved over the past week After last week's 16% share price gain to ₹1,020, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 344% over the past three years. Valuation Update With 7 Day Price Move • Apr 04
Investor sentiment improved over the past week After last week's 19% share price gain to ₹1,129, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 336% over the past three years. Reported Earnings • Feb 14
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹7.75 (down from ₹9.62 in 3Q 2021). Revenue: ₹17.7b (up 97% from 3Q 2021). Net income: ₹240.1m (down 20% from 3Q 2021). Profit margin: 1.4% (down from 3.3% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment improved over the past week After last week's 18% share price gain to ₹926, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 218% over the past three years. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improved over the past week After last week's 17% share price gain to ₹763, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 112% over the past three years. Upcoming Dividend • Sep 09
Upcoming dividend of ₹6.00 per share Eligible shareholders must have bought the stock before 16 September 2021. Payment date: 24 October 2021. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.7%). Reported Earnings • Aug 11
First quarter 2022 earnings released: EPS ₹64.99 (vs ₹1.38 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹6.51b (up 69% from 1Q 2021). Net income: ₹2.01b (up ₹1.97b from 1Q 2021). Profit margin: 31% (up from 1.1% in 1Q 2021). Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment improved over the past week After last week's 39% share price gain to ₹748, the stock trades at a trailing P/E ratio of 18.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 88% over the past three years. Reported Earnings • Jun 27
Full year 2021 earnings released: EPS ₹35.27 (vs ₹37.03 in FY 2020) The company reported a mediocre full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: ₹54.4b (up 56% from FY 2020). Net income: ₹1.09b (down 4.8% from FY 2020). Profit margin: 2.0% (down from 3.3% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jun 05
Investor sentiment improved over the past week After last week's 17% share price gain to ₹549, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 27% over the past three years. 
